STAND. COM. REP. NO. 1071-18

Honolulu, Hawaii

, 2018

RE: H.B. No. 1602

H.D. 2

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

Sir:

Your Committee on Consumer Protection & Commerce, to which was referred H.B. No. 1602, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO OPIOIDS,"

begs leave to report as follows:

The purpose of this measure is to authorize a seller of opioid drugs to warn of the risks of addiction and death by displaying a warning label on the drug container.

The Department of Public Safety, Hawaii Chapter of the American Physical Therapy Association, Oahu County Committee on Legislative Priorities of the Democratic Party of Hawai‘i, Hawaii Substance Abuse Coalition, Walgreen Co., and Ho‘omana Pono, LLC testified in support of this measure. One individual testified in opposition. The Department of Health provided comments.

Your Committee has amended this measure by:

(1) Changing its effective date to July 1, 2050, to promote further discussion; and

(2) Making technical, nonsubstantive amendments for clarity, consistency, and style.

As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1602, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as H.B. No. 1602, H.D. 2.

Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,

____________________________

ROY M. TAKUMI, Chair